BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3362255)

  • 1. [Problems related to high-dose estrogen/progestogen combinations, such as Menstrogen, in India].
    van Keep PA
    Ned Tijdschr Geneeskd; 1988 Feb; 132(8):364-5. PubMed ID: 3362255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems with high-dose estrogen/progestin combinations such as Mestrogen, in India].
    Wolffers I
    Ned Tijdschr Geneeskd; 1988 Jan; 132(1):29-31. PubMed ID: 3352817
    [No Abstract]   [Full Text] [Related]  

  • 3. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
    Wooltorton E
    CMAJ; 2006 Jan; 174(2):164-5. PubMed ID: 16368722
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical evaluation of oral hormones as a diagnostic test for pregnancy.
    Panchalingam S
    Ceylon Med J; 1969 Dec; 14(4):185-7. PubMed ID: 5373986
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of limovanil in pregnancy].
    Gardó S
    Orv Hetil; 1977 Mar; 118(11):660. PubMed ID: 846706
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal pregnancy tests and spina bifida.
    Sever LE
    Nature; 1973 Apr; 242(5397):410-1. PubMed ID: 4573581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen-progestogen agents and megaloblastic anemia].
    Mottier D; Jouquan J; Baccino E; Cleuziou A; Pennec Y; Kerlan V; Garo B; Bergeret G
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):707-10. PubMed ID: 6520357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
    Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL
    Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463
    [No Abstract]   [Full Text] [Related]  

  • 10. Lower- vs higher-dose estrogen for contraception.
    Kripke C
    Am Fam Physician; 2005 Oct; 72(7):1224-5. PubMed ID: 16229072
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
    Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
    J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genital hemorrhage in early pregnancy].
    Staemmler HJ
    Dtsch Med Wochenschr; 1973 Sep; 98(36):1683. PubMed ID: 4741245
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal pregnancy tests and congenital malformation.
    Gal I; Kirman B; Stern J
    Nature; 1967 Oct; 216(5110):83. PubMed ID: 4860722
    [No Abstract]   [Full Text] [Related]  

  • 15. Risks and benefits of the use of hormonal pregnancy test tablets.
    Gal I
    Nature; 1972 Nov; 240(5378):241-2. PubMed ID: 4569422
    [No Abstract]   [Full Text] [Related]  

  • 16. First chewable oral contraceptive.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal contraceptive patch].
    Lidegaard O
    Ugeskr Laeger; 2004 Oct; 166(41):3591. PubMed ID: 15515462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
    Cremer P; Vekemans M
    Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous oral contraception. Strategies for managing breakthrough bleeding.
    Freeman SB
    Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risks of postcoital contraception using a d-norgestrel-ethinyl estradiol combination].
    Welti H; Nguyen Duy N; Zufferey MM
    Ther Umsch; 1986 May; 43(5):438-40. PubMed ID: 3726780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.